Evolus, Inc. (EOLS) financial statements (2022 and earlier)

Company profile

Business Address 520 NEWPORT CENTER DRIVE
NEWPORT BEACH, CA 92660
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments146,256107,562129,80393,162
Cash and cash equivalents146,256102,562109,89293,162
Short-term investments 5,00019,911 
Receivables14,6579,68010,661 
Inventory, net of allowances, customer advances and progress billings1,7623,3546,407 
Inventory1,7623,3546,407 
Prepaid expense5,082   
Other current assets11,042   
Other undisclosed current assets 7,0165,3261,177
Total current assets:178,799127,612152,19794,339
Noncurrent Assets
Operating lease, right-of-use asset2,7223,4144,068
Property, plant and equipment1,3711,297902 
Intangible assets, net (including goodwill)71,83376,50580,84677,284
Goodwill21,20821,20821,20821,208
Intangible assets, net (excluding goodwill)50,62555,29759,63856,076
Other noncurrent assets2,7582402,429221
Total noncurrent assets:78,68481,45688,24577,505
TOTAL ASSETS:257,483209,068240,442171,844
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:29,9939,10213,9605,276
Accounts payable   1,558
Accrued liabilities   3,718
Employee-related liabilities6,8564,0765,229 
Other undisclosed accounts payable and accrued liabilities23,1375,0268,731 
Debt 74,3841,200 
Estimated litigation liability15,00063,421  
Due to related parties 19,068  
Other undisclosed current liabilities12,67014,2739,279 
Total current liabilities:57,663180,24824,4395,276
Noncurrent Liabilities
Long-term debt and lease obligation73,47843,65377,40116,904
Long-term debt, excluding current maturities71,22240,50673,50816,904
Operating lease, liability2,2563,1473,893
Liabilities, other than long-term debt5,04020,025 25
Deferred rent credit   25
Deferred income tax liabilities4025 
Estimated litigation liability5,00020,000  
Other undisclosed noncurrent liabilities39,42638,10059,14565,255
Total noncurrent liabilities:117,944101,778136,54682,184
Total liabilities:175,607282,026160,98587,460
Stockholders' equity
Stockholders' equity attributable to parent81,876(72,958)79,45784,384
Common stock1111
Additional paid in capital504,757303,113292,509207,408
Accumulated other comprehensive income  6 
Accumulated deficit(422,882)(376,072)(213,059)(123,025)
Total stockholders' equity:81,876(72,958)79,45784,384
TOTAL LIABILITIES AND EQUITY:257,483209,068240,442171,844

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues99,67356,54034,925 
Cost of revenue(49,552)(23,319)(8,014) 
Cost of goods and services sold(43,534)(18,299)(8,014) 
Gross profit:50,12133,22126,911 
Operating expenses(94,526)(186,289)(125,858)(46,142)
Operating loss:(44,405)(153,068)(98,947)(46,142)
Nonoperating income (expense)(1,395)(9,868)(6,114)203
Investment income, nonoperating16351,839203
Other nonoperating expense(1,396)(10,503)(7,953) 
Interest and debt expense(968)  (863)
Loss from continuing operations before income taxes:(46,768)(162,936)(105,061)(46,802)
Income tax expense (benefit)(42)(77)15,027(65)
Net loss available to common stockholders, diluted:(46,810)(163,013)(90,034)(46,867)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(46,810)(163,013)(90,034)(46,867)
Comprehensive loss:(46,810)(163,013)(90,034)(46,867)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (6)6 
Comprehensive loss, net of tax, attributable to parent:(46,810)(163,019)(90,028)(46,867)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: